276 related articles for article (PubMed ID: 20626817)
1. Robert Koch redux: malaria immunology in Papua New Guinea.
Stanisic DI; Mueller I; Betuela I; Siba P; Schofield L
Parasite Immunol; 2010 Aug; 32(8):623-32. PubMed ID: 20626817
[TBL] [Abstract][Full Text] [Related]
2. The Malaria Vaccine Epidemiology and Evaluation Project of Papua New Guinea: rationale and baseline studies.
Alpers MP; al-Yaman F; Beck HP; Bhatia KK; Hii J; Lewis DJ; Paru R; Smith TA
P N G Med J; 1992 Dec; 35(4):285-97. PubMed ID: 1341090
[TBL] [Abstract][Full Text] [Related]
3. Malaria vaccine: why is it taking so long?
Corradin G; Kajava AV
Expert Rev Vaccines; 2010 Feb; 9(2):111-4. PubMed ID: 20109019
[No Abstract] [Full Text] [Related]
4. Malaria and colonialism in the German colonies New Guinea and the Cameroons. Research, control, thoughts of eradication.
Eckart WU
Parassitologia; 1998 Jun; 40(1-2):83-90. PubMed ID: 9653735
[TBL] [Abstract][Full Text] [Related]
5. Vaccines against malaria: perspectives from Papua New Guinea.
Mueller I; Genton B; Betuela I; Alpers MP
Hum Vaccin; 2010 Jan; 6(1):17-20. PubMed ID: 20173407
[TBL] [Abstract][Full Text] [Related]
6. Complex patterns of malaria epidemiology in the highlands region of Papua New Guinea.
Mueller I; Taime J; Ibam E; Kundi J; Lagog M; Bockarie M; Reeder JC
P N G Med J; 2002; 45(3-4):200-5. PubMed ID: 12968790
[TBL] [Abstract][Full Text] [Related]
7. Small-area variations in the epidemiology of malaria in Madang Province. 1986.
Cattani JA; Moir JS; Gibson FD; Ginny M; Paino J; Davidson W; Alpers MP
P N G Med J; 2005; 48(1-2):95-101. PubMed ID: 16894841
[No Abstract] [Full Text] [Related]
8. Towards a malaria vaccine for Papua New Guinea.
Reeder JC
P N G Med J; 2001; 44(1-2):17-23. PubMed ID: 12418674
[TBL] [Abstract][Full Text] [Related]
9. The history of malaria control in the southwest Pacific region, with particular reference to Papua New Guinea and the Solomon Islands.
Spencer M
P N G Med J; 1992 Mar; 35(1):33-66. PubMed ID: 1566607
[TBL] [Abstract][Full Text] [Related]
10. A case for whole-parasite malaria vaccines.
Wykes M; Good MF
Int J Parasitol; 2007 Jun; 37(7):705-12. PubMed ID: 17408673
[TBL] [Abstract][Full Text] [Related]
11. A review of the current state of malaria among pregnant women in Papua New Guinea.
Mueller I; Rogerson S; Mola GD; Reeder JC
P N G Med J; 2008; 51(1-2):12-6. PubMed ID: 19999304
[TBL] [Abstract][Full Text] [Related]
12. Malaria vaccine research: lessons from 2008/9.
Haque A; Good MF
Future Microbiol; 2009 Aug; 4(6):649-54. PubMed ID: 19659421
[TBL] [Abstract][Full Text] [Related]
13. Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea.
Stirnadel HA; Beck HP; Alpers MP; Smith TA
Genet Epidemiol; 1999; 17(1):16-34. PubMed ID: 10323182
[TBL] [Abstract][Full Text] [Related]
14. Clinical malaria vaccine development.
Sauerwein RW
Immunol Lett; 2009 Feb; 122(2):115-7. PubMed ID: 19100773
[TBL] [Abstract][Full Text] [Related]
15. Malaria control in Papua New Guinea results in complex epidemiological changes.
Mueller I; Tulloch J; Marfurt J; Hide R; Reeder JC
P N G Med J; 2005; 48(3-4):151-7. PubMed ID: 17212061
[TBL] [Abstract][Full Text] [Related]
16. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
17. Health research in Papua New Guinea.
Reeder JC
Trends Parasitol; 2003 Jun; 19(6):241-5. PubMed ID: 12798079
[TBL] [Abstract][Full Text] [Related]
18. Pre-erythrocytic stage malaria vaccines: time for a change in path.
Druilhe P; Barnwell JW
Curr Opin Microbiol; 2007 Aug; 10(4):371-8. PubMed ID: 17709281
[TBL] [Abstract][Full Text] [Related]
19. Predicting memory: a prospective readout for malaria vaccines?
Minigo G; Scalzo K; Flanagan KL; Plebanski M
Trends Parasitol; 2007 Aug; 23(8):341-3. PubMed ID: 17586093
[TBL] [Abstract][Full Text] [Related]
20. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.
Genton B; Betuela I; Felger I; Al-Yaman F; Anders RF; Saul A; Rare L; Baisor M; Lorry K; Brown GV; Pye D; Irving DO; Smith TA; Beck HP; Alpers MP
J Infect Dis; 2002 Mar; 185(6):820-7. PubMed ID: 11920300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
